60 Results for "

EB

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "EB" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-15046
CAS No.: 366454-36-6
Target:  

PARP

EB-47, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM. EB-47 mimics the substrate NAD + and extends from the nicotinamide to the adenosine subsite .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-108631
CAS No.: 1190332-25-2
Purity:  99.68%
Target:  

PARP

Research Areas:  

Inflammation/Immunology

EB-47 dihydrochloride, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM. EB-47 mimics the substrate NAD +?and extends from the nicotinamide to the adenosine subsite .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0866
CAS No.: 54706-99-9
20-Deoxyingenol, a diterpene, is isolated from the roots of Euphorbia kansui. 20-Deoxyingenol can promote autophagy and lysosomal biogenesis by promoting the nuclear translocation of transcription factor EB (TFEB) in vitro. 20-Deoxyingenol can be used for the research of osteoarthritis (OA) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-K1007

MCE Red Nucleic Acid Gel Stain (10,000×) is a nucleic acid stain that can be used as a safer alternative to the traditional ethidium bromide (EB) stain for detecting nucleic acids in agarose gels or polyacrylamide gels.

loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-115463
CAS No.: 1839150-63-8
Purity:  99.57%
Target:  

AMPK Apoptosis

Research Areas:  

Cancer

EB-3D is a potent and selective choline kinase α (ChoKα) inhibitor, with an IC50 of 1 μM for ChoKα1. EB-3D exerts effects on ChoKα expression, AMPK activation, apoptosis, endoplasmic reticulum stress and lipid metabolism. EB-3D exhibits a potent antiproliferative activity in a panel of T-leukemia cell lines. Anti-cancer activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-32341
CAS No.: 134404-52-7
Synonyms: EB 1089
Target:  

VD/VDR

Research Areas:  

Cancer

Seocalcitol is a vitamin D analog, binds vitamin D receptor protein from human osteosarcoma MG-63 cells with Kd of 0.27 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107801
CAS No.: 36703-88-5
Purity:  98.11%
Synonyms: Imunovir; Delimmun; Groprinosin
Inosine pranobex is an orally active immunomodulator. Inosine pranobex has broad-spectrum antiviral activity. Inosine pranobex inhibits human immunodeficiency virus (HIV), herpes simplex virus (HSV), vaccinia virus (VACV), human tumor virus (HPV), Cytomegalovirus, influenza virus (INFV), parainfluenza virus (PIV), and Epstein-Barr virus .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17485
CAS No.: 39718-89-3
Synonyms: EB-382
Target:  

Phospholipase COX

Research Areas:  

Inflammation/Immunology

Alminoprofen (EB-382) is a nonsteroidal anti-inflammatory agent (NSAID) of the phenylpropionic acid class. Alminoprofen possesses a dual anti-inflammatory action, by inhibiting both secretory phospholipase A2 (sPLA2) and COX-2 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18332A
CAS No.: 410074-74-7
Synonyms: DOV-21947 hydrochloride; EB-1010 hydrochloride
Amitifadine (DOV-21947; EB-1010) hydrochloride is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), with IC50s of 12, 23, 96 nM for serotonin, norepinephrine and dopamine in HEK 293 cells , respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124582
CAS No.: 1361198-80-2
Purity:  ≥98.0%
Target:  

Autophagy mTOR

Research Areas:  

Cancer

NEO214 is an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram (HY-16900) and perillyl alcohol (HY-N7000). It has anti-cancer activity and blood-brain barrier (BBB) permeability. Over sex. NEO214 prevents autophagy-lysosome fusion, thereby blocking autophagic flux and triggering glioma cell death. The process involves mTOR activation, andTFEB(Transcription Factor EB) aggregation. NEO214 inhibitionMacroautophagy/autophagy in glioblastoma cells has the potential to overcome chemotherapy resistance in glioblastoma .
loading...
    loading...
Cat. No.: HY-P10746
CAS No.: 2770688-48-5
Target:  

Neurokinin Receptor

Research Areas:  

Metabolic Disease

EB1002 is a highly selective, long-acting NK2R agonist. EB1002 exerts central appetite suppression, increases peripheral energy expenditure and enhances insulin sensitivity, which effectively reduces body weight, improves glucose and lipid metabolism, with favorable safety profiles. EB1002 can be used for research on diseases such as obesity and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-W010255
CAS No.: 611-73-4
Synonyms: Benzoylformic acid
Phenylglyoxylic acid (Benzoylformic acid) is a metabolite of ethylbenzene and styrene (EB/S) and can be used as a biomarker of exposure to EB/S in human. Phenylglyoxylic acid can be used as drug intermediate for synthesis of antineoplastic compounds .
loading...
    loading...
Cat. No.: HY-16736A
CAS No.: 923981-14-0
Synonyms: EB-1020 hydrochloride
Centanafadine (hydrochloride) is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively.
loading...
    loading...
Cat. No.: HY-142647
CAS No.: 2390475-81-5
Purity:  99.62%
Target:  

LRRK2

Research Areas:  

Neurological Disease

EB-42486 is a novel, potent, and highly selective G2019S-LRRK2 inhibitor (IC50: < 0.2 nM). EB-42486 can be used in the research of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-146805
CAS No.: 42951-68-8
Purity:  99.91%
Research Areas:  

Cancer

EB1 is the inhibitor of kinases MNK with IC50s of 0.69 μM (MNK1) and 9.4 μM (MNK2). EB1 selectively inhibits the growth of cancer cells, but not normal cells. EB1 also increases cell apoptosis and suppresses eIF4E phosphorylation .
loading...
    loading...
Cat. No.: HY-D1773
CAS No.: 156312-20-8
YOYO-3 is a trimethine cyanine homodimer dye. YOYO-3 intercalates into AF488-tagged dsDNA molecules at the single-molecule level. YOYO-3 has a greater affinity for DNA than do EB and other Cyanine dyes .
loading...
    loading...
Cat. No.: HY-P10741
CAS No.: 2151063-66-8
DOTA-EB-TATE is composed of SST peptide derivative, DOTA-octreotate conjugated a common to an Evans blue analog (EB). DOTA-EB-TATE is a peptide drug conjugate (PDC) improves the pharmacokinetics of SSTR2 analogs and reduces PRRT toxicity. DOTA-EB-TATE can also be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .
loading...
    loading...
Cat. No.: HY-P4118
CAS No.: 952754-66-4
Synonyms: Penetrating analog
EB1 peptide (Penetrating analog) is an endosomolytic agent and siRNA delivery agent. EB1 peptide forms an amphipathic alpha helix upon protonation in early-late endosomes, drives endosomal membrane permeabilization, and enables endocytosed siRNA escape into the cytosol. EB1 peptide facilitates biologically active siRNA cellular uptake and targeted gene silencing. EB1 peptide forms complexes with siRNA. EB1 peptide can be used for drug delivery research .
loading...
    loading...
Cat. No.: HY-173364
CAS No.: 3114073-95-6
Synonyms: BAK-04-212
Target:  

BCL6

Research Areas:  

Cancer

EB-TCIP (BAK-04-212) is a proof-of-concept tool specifically designed for Ewing sarcoma research, serving as an EWSR1::FLI1 binder tagged with BCL6 and FKBP12 F36V. EB-TCIP forms a ternary complex with the tagged fusion protein, specifically recruits EWSR1::FLI1 to BCL6-bound DNA loci, and induces rapid chromatin remodeling and relocalization. By mediating relocalization, EB-TCIP remodels the transcriptional machinery and activates the expression of BCL6 target genes that are originally repressed. EB-TCIP is used in studies related to novel epigenetic therapies for Ewing sarcoma .
loading...
    loading...
Cat. No.: HY-159770A
CAS No.: 2740747-99-1
Research Areas:  

Cancer

(S)-EB-FAPI-B2 (Compound II-11) is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging .
loading...
    loading...